Literature DB >> 12213269

Haloperidol-induced alteration in the physiological actions of group I mGlus in the subthalamic nucleus and the substantia nigra pars reticulata.

M J Marino1, H Awad-Granko, K J Ciombor, P J Conn.   

Abstract

Excitatory glutamatergic inputs to the subthalamic nucleus (STN), and subthalamic afferents to the substantia nigra pars reticulata (SNr) are believed to play a key role in the pathophysiology of Parkinson's disease (PD). Previously, we have shown that activation of the group I mGlus in the STN and SNr induces a direct depolarization of the neurons in these nuclei. Surprisingly, although both group I mGlus were present in the STN and SNr, mGlu5 alone mediated the DHPG-induced depolarization of the STN, and mGlu1 alone mediated the DHPG-induced depolarization of the SNr. We now report that both mGlu1 and mGlu5 are coexpressed in the same cells in both of these brain regions, and that both receptors play a role in mediating the DHPG-induced increase in intracellular calcium. Furthermore, we demonstrate that the induction of an acute PD-like state using a 16 h haloperidol treatment produces an alteration in the coupling of the group I receptors, such that post-haloperidol, DHPG-induced depolarizations are mediated by both mGlu1 and mGlu5 in the STN and SNr. Therefore, the pharmacology of the group I mGlu-mediated depolarization depends on the state of the system, and alterations in receptor coupling may be evident in pathological states such as PD.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12213269     DOI: 10.1016/s0028-3908(02)00097-7

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  9 in total

1.  Metabotropic glutamate 5 receptor blockade alleviates akinesia by normalizing activity of selective basal-ganglia structures in parkinsonian rats.

Authors:  Nathalie Breysse; Marianne Amalric; Pascal Salin
Journal:  J Neurosci       Date:  2003-09-10       Impact factor: 6.167

2.  Divergent acute and chronic modulation of glutamatergic postsynaptic density genes expression by the antipsychotics haloperidol and sertindole.

Authors:  Felice Iasevoli; Carmine Tomasetti; Federica Marmo; Daniele Bravi; Jørn Arnt; Andrea de Bartolomeis
Journal:  Psychopharmacology (Berl)       Date:  2010-07-23       Impact factor: 4.530

3.  The metabotropic glutamate receptor 8 agonist (S)-3,4-DCPG reverses motor deficits in prolonged but not acute models of Parkinson's disease.

Authors:  Kari A Johnson; Carrie K Jones; Mohammed N Tantawy; Michael Bubser; Marketa Marvanova; M Sib Ansari; Ronald M Baldwin; P Jeffrey Conn; Colleen M Niswender
Journal:  Neuropharmacology       Date:  2012-04-21       Impact factor: 5.250

4.  Therapeutic potential of targeting metabotropic glutamate receptors for Parkinson's disease.

Authors:  Jonathan W Dickerson; P Jeffrey Conn
Journal:  Neurodegener Dis Manag       Date:  2012-04-01

5.  Group I mGluRs evoke K-ATP current by intracellular Ca2+ mobilization in rat subthalamus neurons.

Authors:  Ke-Zhong Shen; Steven W Johnson
Journal:  J Pharmacol Exp Ther       Date:  2013-01-18       Impact factor: 4.030

Review 6.  Glutamate receptors as therapeutic targets for Parkinson's disease.

Authors:  Kari A Johnson; P Jeffrey Conn; Colleen M Niswender
Journal:  CNS Neurol Disord Drug Targets       Date:  2009-12       Impact factor: 4.388

7.  Allosteric potentiators of metabotropic glutamate receptor subtype 1a differentially modulate independent signaling pathways in baby hamster kidney cells.

Authors:  Douglas J Sheffler; P Jeffrey Conn
Journal:  Neuropharmacology       Date:  2008-07-02       Impact factor: 5.250

8.  Localization and expression of group I metabotropic glutamate receptors in the mouse striatum, globus pallidus, and subthalamic nucleus: regulatory effects of MPTP treatment and constitutive Homer deletion.

Authors:  Masaaki Kuwajima; Marlin H Dehoff; Teiichi Furuichi; Paul F Worley; Randy A Hall; Yoland Smith
Journal:  J Neurosci       Date:  2007-06-06       Impact factor: 6.167

9.  Endogenous activation of mGlu5 metabotropic glutamate receptors contributes to the development of nigro-striatal damage induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice.

Authors:  Giuseppe Battaglia; Carla L Busceti; Gemma Molinaro; Francesca Biagioni; Marianna Storto; Francesco Fornai; Ferdinando Nicoletti; Valeria Bruno
Journal:  J Neurosci       Date:  2004-01-28       Impact factor: 6.167

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.